Christopher McCarthy
Fortuna: 490 233 $ al 31/08/2026
Fortuna: 490 233 $ al 31/08/2026
Christopher McCarthy is Chief Financial & Operating Officer at Interpace Biosciences, Inc. since 2023.
Formerly, Mr. McCarthy was Senior Financial Systems Analyst at Simon & Schuster LLC from 2016 to 2019.
Mr. McCarthy completed undergraduate and Masters of Business Administration degrees at William Paterson University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/08/2026 | 64.760 ( 1,1 % ) | 490 233 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Director Financiero/CFO | 21/04/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Simon & Schuster LLC
Simon & Schuster LLC Publishing: Books/MagazinesConsumer Services Publishes and sells English language books | Corporate Officer/Principal | 01/06/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Interpace Biosciences, Inc.
Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Simon & Schuster LLC
Simon & Schuster LLC Publishing: Books/MagazinesConsumer Services Publishes and sells English language books | Consumer Services |
William Paterson University
William Paterson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.